- Home
- NXN vs SRZN Comparison
NXN vs SRZN Comparison
Compare NXN & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXN
- SRZN
- Stock Information
- Founded
- NXN 1992
- SRZN 2015
- Country
- NXN United States
- SRZN United States
- Employees
- NXN N/A
- SRZN N/A
- Industry
- NXN Trusts Except Educational Religious and Charitable
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- NXN Finance
- SRZN Health Care
- Exchange
- NXN Nasdaq
- SRZN Nasdaq
- Market Cap
- NXN 46.2M
- SRZN 37.7M
- IPO Year
- NXN N/A
- SRZN N/A
- Fundamental
- Price
- NXN $11.73
- SRZN $11.86
- Analyst Decision
- NXN
- SRZN Strong Buy
- Analyst Count
- NXN 0
- SRZN 2
- Target Price
- NXN N/A
- SRZN $38.50
- AVG Volume (30 Days)
- NXN 9.7K
- SRZN 12.7K
- Earning Date
- NXN 01-01-0001
- SRZN 05-07-2025
- Dividend Yield
- NXN 4.23%
- SRZN N/A
- EPS Growth
- NXN N/A
- SRZN N/A
- EPS
- NXN 0.24
- SRZN N/A
- Revenue
- NXN N/A
- SRZN $10,655,000.00
- Revenue This Year
- NXN N/A
- SRZN N/A
- Revenue Next Year
- NXN N/A
- SRZN N/A
- P/E Ratio
- NXN $48.42
- SRZN N/A
- Revenue Growth
- NXN N/A
- SRZN N/A
- 52 Week Low
- NXN $10.64
- SRZN $6.00
- 52 Week High
- NXN $12.45
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- NXN 48.14
- SRZN 52.87
- Support Level
- NXN $11.71
- SRZN $10.34
- Resistance Level
- NXN $11.86
- SRZN $12.93
- Average True Range (ATR)
- NXN 0.09
- SRZN 1.07
- MACD
- NXN -0.00
- SRZN -0.01
- Stochastic Oscillator
- NXN 50.00
- SRZN 45.18
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).